A team at the Menzies Research Institute are the first to demonstrate the harmful effects of cigarette smoking on knee osteoarthritis (OA), primarily with a person with a family history of knee OA.
Ultra-high-field (7T) MRI can detect multiple sclerosis lesions better than MRI which can lead to possible earlier diagnosis and treatment, according to a new study by researchers from Ohio State University in Columbus, and Columbia University in New York.
MRI and MRS can provide a roadmap of the prostate and assist in surgical planning of robotically assisted laparoscopic radical prostatectomy, according to a recent study conducted by researchers at the University of California, Los Angeles.
Ultra-high-field MRI can detect multiple sclerosis lesions better than MRI which can lead to possible earlier diagnosis and treatment, according to a new study by researchers from Ohio State University in Columbus, and Columbia University in New York.
Drinking heavy amounts of alcohol over a long period of time may decrease brain volume, according to research that will be presented at the American Academy of Neurology’s 59th Annual Meeting in Boston, April 28 ? May 5, 2007.
Genentech, Inc. (NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BIIB) announced that positive data from a Phase II clinical study of Rituxan? (rituximab) in patients with relapsing-remitting multiple sclerosis (RRMS) were presented at the American Academy of Neurology annual meeting held in Boston.
Elderly men and women who consumed higher levels of calcium and vitamin D are significantly more likely to have greater volumes of brain lesions, regions of damage that can increase risk of cognitive impairment, dementia, depression and stroke.
A part of the brain first affected by Alzheimer’s disease is thinner in youth with a risk gene for the disorder, a brain imaging study by researchers at the National Institute of Mental Health (NIMH), one of the National Institutes of Health (NIH), has found.
‘Pediatric Multiple Sclerosis and Related Disorders’ has just been published by the International Pediatric MS Study Group as a supplement to the journal Neurology. The Group was founded by the National MS Society (USA) to foster global cooperation in studying and addressing the challenges associated with what is generally thought of as an adult neurological disease when it occurs in a non-adult population.
A phase II clinical trial of an angiogenesis inhibitor to treat glioblastoma has shown promise in a majority of patients tested, say researchers at Massachusetts General Hospital and Harvard Medical School.